Buscar resultados de ensayos clínicos
Hypereosinophilic Syndrome - 25 Studies Found
Estado | Estudiar |
Available |
Nombre del estudio: This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES 201956: A Long-term Access Programme for Subjects With Severe Asthma Condición: Hypereosinophilic Syndrome Fecha: 2005-10-25 Intervenciones: Drug: Mepolizumab open label investigational product |
Completed |
Nombre del estudio: Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes Condición:
Fecha: 2008-11-06 Intervenciones: Drug: Imatinib Patients received oral imatinib 100 mg/d; in case of unsatisfactory response (less than c |
Completed |
Nombre del estudio: Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias Condición:
|
Recruiting |
Nombre del estudio: Eosinophilia Diagnosis Condición: Hypereosinophilic Syndrome Fecha: 2015-10-19 Intervenciones: Other: Scheduled exams and diagnosis Scheduled exams and diagnosis circuit as imposed by the algorithm |
Recruiting |
Nombre del estudio: Steroid Treatment for Hypereosinophilic Syndrome Condición: Hypereosinophilia Fecha: 2012-02-01 Intervenciones: Drug: Corticosteroids |
Completed |
Nombre del estudio: 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) Condición: Leukemia Fecha: 2007-06-05 Intervenciones:
|
Completed |
Nombre del estudio: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Condición:
Fecha: 2005-12-15 Intervenciones: Drug: Mepolizumab 10mg/kg (max 750 ml) once a month for 3 months |
Completed |
Nombre del estudio: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate Condición:
|
Completed |
Nombre del estudio: Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Condición:
|
Completed |
Nombre del estudio: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Condición:
Intervenciones: Drug: imatinib mesylate Other Name: STI571 |